A randomized comparison of low-molecular-weight heparin (enoxaparin) and unfractionated heparin adjunctive to t-PA thrombolysis and aspirin (HART-II)

被引：0
|
作者：
Molhoek, GP
Knudtson, M
Lundergan, CF
de Jong, E
Schwartz, W
Coyne, K
Draoui, Y
Regalado, L
Ross, AM
机构：
[1] Medisch Spectrum Twente, Enschede, Netherlands
[2] Foothills Hosp, Calgary, AB T2N 2T9, Canada
[3] George Washington Univ, Washington, DC USA
[4] Aventis, Collegeville, PA USA
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3269
引用
收藏
页码：600 / 600
页数：1
相关论文
共 50 条
  • [31] Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?
    Senturk, Aysegul
    Ucar, Elif Yilmazel
    Berk, Serdar
    Ozlu, Tevfik
    Altinsoy, Bulent
    Dabak, Gul
    Cakir, Ebru
    Kadioglu, Esra Ekbic
    Sen, Hadice Selimoglu
    Ozsu, Savas
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (04) : 395 - 399
  • [32] SUBCUTANEOUS HEPARIN TREATMENT OF DEEP VENOUS THROMBOSIS - A COMPARISON OF UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN
    HOLM, HA
    LY, B
    HANDELAND, GF
    ABILDGAARD, U
    ARNESEN, KE
    GOTTSCHALK, P
    HOEG, V
    AANDAHL, M
    HAUGEN, K
    LOERUM, F
    SCHEEL, B
    SORTLAND, O
    VINJE, B
    HAEMOSTASIS, 1986, 16 : 30 - 37
  • [33] Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis For Severity Pulmonary Embolism?
    Ozlu, T.
    Senturk, A.
    Ucar, E. Y.
    Berk, S.
    Altinsoy, B.
    Dabak, G.
    Cakir, E.
    Kadioglu, E. E.
    Sen, H. S.
    Ozsu, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Effect of low-molecular-weight heparin (Tinzaparin) and unfractionated heparin on platelet aggregation
    Ravn, HB
    Bregengaard, C
    Vissinger, H
    Ostergaard, P
    Holst, J
    Nielsen, HK
    Kristensen, SD
    Husted, SE
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 (03) : 209 - 212
  • [35] Low-molecular-weight heparin vs unfractionated heparin in acute coronary syndromes
    Schreiber, Richard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (20): : 2353 - 2353
  • [36] Isolation and Characterization of Contaminants in Recalled Unfractionated Heparin and Low-Molecular-Weight Heparin
    Viskov, Christian
    Bouley, E.
    Hubert, P.
    Martinez, Celine
    Herman, F.
    Jeske, Walter
    Hoppensteadt, Debra
    Walenga, Jeanine M.
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (04) : 395 - 401
  • [37] Fixed-dose unfractionated heparin vs low-molecular-weight heparin
    Edwards, Jonathan Lee
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03): : 262 - 262
  • [38] DELAYED CUTANEOUS REACTION TO UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN AND DANAPAROID
    SIVAKUMARAN, M
    GHOSH, K
    MUNKS, R
    GELSTHORPE, K
    TAN, L
    WOOD, JK
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 893 - 894
  • [39] Prophylactic Low-Molecular-Weight Heparin Versus Unfractionated Heparin at the Time of Delivery
    Pluym, Ilina D.
    Holliman, Kerry
    Bermudez, Ana
    Afshar, Yalda
    Silverman, Neil S.
    Rao, Rashmi
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 132S - 132S
  • [40] Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin
    Spinler, SA
    Wittkowsky, AK
    Nutescu, EA
    Smythe, MA
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1275 - 1285
12345